Connect with us
Novartis CEO said that the pharmaceutical company's strategy involves not exceeding acquisitions of more than $5 billion. The agreement with Cytokinetics meant a larger investment, since,...
Janssen increased its profit to €72.2 million last year. In total, Johnson&Johnson expects year-end revenue to be between $93 billion and $93.5 billion, while it expects...
Pfizer closed the first quarter of 2022 with a profit of $7.86 billion, up from $4.88 billion collected between January and March 2021. The pharma developer...
Pfizer, Johnson&Johnson (J&J) and AstraZeneca achieved a combined profit of $42.972 billion in 2021, up from $27.017 billion a year earlier, according to results released by...
Johnson&Johnson, AstraZeneca, Moderna and Pfizer raised their cash in 2020, amounting to a total of $ 28.85 billion. For its part, AstraZeneca increased its cash flow...